The advanced autoantibody panel, Neural Zoomer Plus , screens for immune reactivity to key neural targets, including myelin basic protein, NMDA receptors, gangliosides, synapsin, S100B, and blood-brain barrier proteins
Our mission is to provide the highest quality compounded solutions while leading the industry in compliance, safety, provider education, and customer service, thereby empowering healthcare providers with the ability to optimize the health of their patients
Supporting gut barrier integrity with BPC-157 could reduce one known trigger of autoimmune activation
Due to risk of severe adverse reactions, do not use Bexacat in cats with evidence of hepatic disease or reduced renal function